Harvard Apparatus Regenerative Technology, Inc. Stockholders Equity

Quick Answer

Harvard Apparatus Regenerative Technology, Inc. reported Stockholders Equity of $1.06 million for fiscal year 2025.

Harvard Apparatus Regenerative Technology, Inc. Stockholders Equity — Annual History

Fiscal Year Stockholders Equity YoY Change
2025 $1.06M -67.2%
2024 $3.22M +95.7%
2023 $1.65M +151.6%
2022 -$3.19M -5.3%
2021 -$3.03M -369.2%
2020 $1.12M +3.3%
2019 $1.09M -44.7%
2018 $1.97M -42.4%
2017 $3.42M +93.0%
2016 $1.77M -78.6%
2015 $8.30M +27.8%
2014 $6.49M -55.4%
2013 $14.57M +53859.3%
2012 $27.0K +22.7%
2011 $22.0K

Quarterly Stockholders Equity

Quarter Ending Stockholders Equity YoY QoQ
September 30, 2025 $1.55M -59.5% +104.2%
June 30, 2025 $761.0K +362.4% -62.8%
March 31, 2025 $2.05M +1070.3% -36.4%
December 31, 2024 $3.22M +95.7% -16.1%
September 30, 2024 $3.84M +41.4% +1424.1%
June 30, 2024 -$290.0K -107.6% -265.7%
March 31, 2024 $175.0K +116.5% -89.4%
December 31, 2023 $1.65M +151.6% -39.4%
  • Harvard Apparatus Regenerative Technology, Inc. showed a decrease of -67.2% in Stockholders Equity compared to the prior fiscal year.
  • Over the 2011–2025 period, Harvard Apparatus Regenerative Technology, Inc.’s stockholders equity has grown by 4704.5% (from $22.0 thousand to $1.06 million).
  • The most recent figure is from Harvard Apparatus Regenerative Technology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment